HOME >> BIOLOGY >> NEWS
Basis of rare genetic illness leads to better understanding of bone formation, Hopkins researchers find

Scientists at Johns Hopkins and three other centers have found that defects in GNAS1, a hormone sensitivity gene, are responsible for progressive osseus heteroplasia (POH), a disease that causes rice-size bone fragments to spontaneously form under the skin and inside internal organs.

The finding, reported in this week's New England Journal of Medicine, also represents a major step forward in identifying the genes responsible for normal bone formation in children and adults, a process that has largely mystified scientists.

"This new knowledge will allow us to design medical treatments that block problem-causing bone fragments in patients," says Children's Center endocrinologist Michael Levine, M.D., a principal investigator of the research project. "But the real excitement, I think, comes from understanding POH as a model for new bone formation. This in turn may help us discover new agents that induce new bone growth and that may be useful treatments for many other bone problems, including osteoporosis and bone fractures."

The research may also prove important to core geneticists because of the role "genomic imprinting" plays in the expression of the defective GNAS1 gene. When a gene is imprinted, only one gene in the pair will be active in each cell. As yet, few concrete examples of genetic imprinting exist for researchers to study.

GNAS1 (guanine nucleotide binding protein alpha stimulating activity polypeptide) provides the DNA blueprint for Gs-alpha, a protein that plays a critical role in a cell's ability to respond to its external environment. Part of an elegantly complex metabolic system called a signal transduction pathway, Gs-alpha at normal levels allows cells to respond to hormones by influencing which genes are turned on and off, as well as controlling the action of many proteins. A defect in GNAS1 prevents cells from responding to hormones. In POH's case, this leads to the synthesis of bone by affected cells.

Th
'"/>

Contact: David Bricker
dbricker@jhmi.edu
410-223-1728
Johns Hopkins Medical Institutions
9-Jan-2002


Page: 1 2

Related biology news :

1. UCSF-Led Team Offers New Insight Into Neurological Basis Of Dyslexia
2. IUPAC, IUPHAR, And IUTOX Publish A Report On Natural And Anthropogenic Environmental Oestrogens: The Scientific Basis For Risk Assessment
3. Reversible Process For Forming Supramolecular Polymers Could Be The Basis Of Fibers, Molecular Transport Mechanisms
4. UCSD And NIH Researchers Isolate Candidates For Genetic Basis Of Human Taste
5. Old Bone Collection Reveals Basis For Some Dizziness
6. Insurance Industry Discriminates Unfairly On Basis Of Genetic Information
7. Molecular Basis Of Leading Genetic Cause Of Infant Death Discovered
8. Adaptations Basis May Be A Mix Of Genetic Tweaks, Whoppers
9. The Genetic Basis Of Childhood Schizophrenia
10. Hormone Control Of Rare Leukemia Sheds Light On Molecular Basis Of Cancer
11. New Description Of Protein May Be Basis For Regulating Cholesterol

Post Your Comments:
(Date:5/21/2013)... ANN ARBORThe new University of Michigan Water Center ... to support Great Lakes restoration and protection efforts. ... will support diverse projects, including efforts to track ... effectiveness of techniques to control non-native weedy plant ... and monitor fish responses to restoration activities. , ...
(Date:5/21/2013)... scientists have developed many devices that can reopen clogged ... effective, each of these treatments has drawbacks, including the ... MIT analyzes the potential usefulness of a new treatment ... stents, but may pose fewer risks. With this new ... only a brief period, during which it releases a ...
(Date:5/20/2013)... are also commonly resistant to antimicrobial substances made ... in mBio , the online open-access journal ... colistin and host antimicrobials LL-37 and lysozyme, which ... mean that patients with life-threatening multi-drug resistant infections ... Colistin is a last-line drug for treating several ...
Breaking Biology News(10 mins):U-M Water Center awards $570K in Great Lakes restoration grants 2U-M Water Center awards $570K in Great Lakes restoration grants 3U-M Water Center awards $570K in Great Lakes restoration grants 4Evaluating a new way to open clogged arteries 2Evaluating a new way to open clogged arteries 3Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3
(Date:5/22/2013)... NEW YORK , May 22, 2013 /PRNewswire/ ... pioneering the development of disease modifying therapeutics for ... today the completion of its Series B financing, ... shares and warrants that would represent approximately $2.8M ... investors and new investors supported the raise. ...
(Date:5/22/2013)... N.H. , May 22, 2013  Superior ... the Year 2013" by Business NH Magazine.  For ... Granite State organizations that distinguish themselves with extraordinary ... very proud to receive this honor," said ... Controls.  "As with any recognition, this award is ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Genedata, ... industrial biotechnology, drug discovery, and life science research, ... Selector ™ as its bioinformatics platform for ... organisms. Genedata will provide AB Enzymes, one of ... a hosted solution of Genedata Selector accompanied by ...
(Date:5/22/2013)... 22, 2013 AudioNotch ... for tinnitus treatment. AudioNotch is pleased to announce ... clinic locations in both British Columbia and Alberta, ... and hearing services. AudioNotch's tinnitus treatment program is ... entering a Destination Hearing clinic, patients have the ...
Breaking Biology Technology:Oligomerix, Inc. Completes Series B Financing 2Oligomerix, Inc. Completes Series B Financing 3Superior Controls of Seabrook, NH named Business of the Year for 2013 by Business NH Magazine 2AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 2AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 3AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 4AudioNotch Tinnitus Treatment Launches Partnership With Destination Hearing 2
Cached News: